GTSF1L Activators
GTSF1L activators are a class of compounds that, although not directly interacting with GTSF1L itself, can influence cellular pathways to enhance the functional activity of GTSF1L. These compounds act on a diverse range of targets, such as adenylate cyclase, DNA methyltransferases, sirtuin 1, NF-κB, GSK-3, retinoic acid receptors, histone deacetylases, Syk kinase, Nrf2, PI3K, MEK, and TGF-β receptor, indicating the extensive network of cellular signaling that can intersect with the activity of GTSF1L. The chemical actions range from modifying secondary messenger levels, as seen with forskolin's effect on cAMP, to changing gene expression patterns through epigenetic modifications induced by agents like epigallocatechin gallate and sodium butyrate.
The indirect activation of GTSF1L through these compounds could potentially occur through the stabilization of protein structure, alteration of gene transcription, or modulation ofprotein phosphorylation states. Forskolin, by raising cAMP levels, can enhance PKA activity, which may phosphorylate proteins that interact with or regulate GTSF1L activity. Similarly, compounds like resveratrol and curcumin can influence the activity of GTSF1L indirectly by activating or inhibiting enzymes like SIRT1 and NF-κB, respectively, which leads to changes in the cellular environment that could favor GTSF1L activation. Lithium's inhibition of GSK-3, retinoic acid's modulation of gene expression via RAR activation, and the inhibition of HDAC by sodium butyrate all exemplify the multifaceted approaches these compounds take to create a cellular context that can enhance GTSF1L activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, which increases cyclic AMP (cAMP) levels in cells. Elevated cAMP levels can enhance protein kinase A (PKA) activity, which may phosphorylate and thereby activate proteins downstream, potentially including GTSF1L as part of a signaling cascade. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, which could lead to reduced methylation of the GTSF1L promoter, indirectly enhancing its expression and functional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuin 1 (SIRT1), which is involved in deacetylating histones and other proteins. This activation can lead to changes in chromatin structure and gene expression, potentially upregulating GTSF1L activity. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can inhibit NF-κB activation, which might lead to a decrease in the expression of inflammatory genes and an increase in the expression of genes that are suppressed by NF-κB, including potentially GTSF1L. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is a known inhibitor of glycogen synthase kinase 3 (GSK-3). Inhibition of GSK-3 could stabilize proteins and enhance signaling pathways that may indirectly increase the activity of GTSF1L. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression by activating retinoic acid receptors (RARs). This can lead to altered expression of genes that are co-regulated with GTSF1L, thereby enhancing its functional activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase (HDAC) inhibitor, which leads to increased acetylation of histones and a more open chromatin structure, potentially increasing the expression and activity of GTSF1L. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol inhibits the activity of Syk kinase, which may modulate signaling pathways that indirectly lead to the activation of GTSF1L. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane activates the Nrf2 pathway, which regulates the expression of antioxidant response element (ARE)-driven genes, potentially enhancing the functional activity of GTSF1L if it is ARE-responsive. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter the AKT signaling pathway. This alteration might influence the activity of GTSF1L if it is part of the PI3K/AKT pathway. | ||||||